APA (7th ed.) Citation

Wang, X., Duan, W., Ma, Z., Wen, H., Mao, X., & Liu, C. ETV4/ALYREF-mediated glycolytic metabolism through PKM2 enhances resistance to ferroptosis and promotes the development of intrahepatic cholangiocarcinoma. BMC.

Chicago Style (17th ed.) Citation

Wang, Xiaohui, Wenbin Duan, Zhongzhi Ma, Haoquan Wen, Xianhai Mao, and Changjun Liu. ETV4/ALYREF-mediated Glycolytic Metabolism Through PKM2 Enhances Resistance to Ferroptosis and Promotes the Development of Intrahepatic Cholangiocarcinoma. BMC.

MLA (9th ed.) Citation

Wang, Xiaohui, et al. ETV4/ALYREF-mediated Glycolytic Metabolism Through PKM2 Enhances Resistance to Ferroptosis and Promotes the Development of Intrahepatic Cholangiocarcinoma. BMC.